ARCHIVES

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Biomira Ends Agreement On Lymphoma Vaccine.

May 4, 2001

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

In Brief: St. Jude, Yale to Get Bristol-Myers Grants; Five Named for New Young Scientists Awards

May 6, 1988

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003